Jiawei Wendantang Regulates NF-κB/NLRP3 Pathway to Reduce Inflammation in Rat Model of Diabetic Atherosclerosis
|更新时间:2024-06-14
|
Jiawei Wendantang Regulates NF-κB/NLRP3 Pathway to Reduce Inflammation in Rat Model of Diabetic Atherosclerosis
“The latest research found that Jiawei Wendan Decoction can effectively prevent and treat atherosclerosis in diabetes by regulating the NF - κ B/NLRP3 signaling pathway, reducing the release and adhesion of inflammatory factors, regulating blood sugar.”
Chinese Journal of Experimental Traditional Medical FormulaeVol. 30, Issue 14, Pages: 71-77(2024)
LIU Chao,WANG Lin,YAO Fengyu,et al.Jiawei Wendantang Regulates NF-κB/NLRP3 Pathway to Reduce Inflammation in Rat Model of Diabetic Atherosclerosis[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(14):71-77.
LIU Chao,WANG Lin,YAO Fengyu,et al.Jiawei Wendantang Regulates NF-κB/NLRP3 Pathway to Reduce Inflammation in Rat Model of Diabetic Atherosclerosis[J].Chinese Journal of Experimental Traditional Medical Formulae,2024,30(14):71-77. DOI: 10.13422/j.cnki.syfjx.20240521.
Jiawei Wendantang Regulates NF-κB/NLRP3 Pathway to Reduce Inflammation in Rat Model of Diabetic Atherosclerosis